North America Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Penetrating Keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and Others], Indication (Fungal Corneal Ulcer, Fuchs Dystrophy, Keratoconus, Keratitis, and Others), and End User (Hospitals, Eye Clinic, and Ambulatory Surgical Centers)

TIPRE00029096 | Pages: 105 | Medical Device | May 2022 | Type: Regional | Status: Published

The North America corneal transplantation market is expected to grow from US$ 207.03 million in 2021 to US$ 318.25 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2021 to 2028.

 

Corneal blindness includes a broad spectrum of infectious and inflammatory eye diseases causing corneal scars that lead to functional blindness. Trachoma, corneal ulcers, ophthalmia neonatorum, xerophthalmia, viral infections, onchocerciasis, leprosy, traditional eye medications, and eye injuries lead to corneal blindness. Despite having complex epidemiology, corneal blindness can be prevented with the timely treatment of the abovementioned diseases. However, if left untreated in the initial stage due to limited access to medical care, corneal transplantation is the only option for treating patients with damaged corneas. According to 2020 statistics from the Cornea Research Foundation of America, keratoconus disorder affects ~50–200 out of every 100,000 people. Thus, the growing incidence of eye diseases, including keratoconus disorders, is bolstering the growth of the North America corneal transplantation market.

 

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America corneal transplantation market at a good CAGR during the forecast period.

 

North America Corneal Transplantation Market Revenue and Forecast to 2028 (US$ Million)

North America Corneal Transplantation Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

  

North America Corneal Transplantation Market Segmentation

 

The North America corneal transplantation market is segmented based on type, indication, end user, and country. Based on type, the North America corneal transplantation market is segmented into penetrating keratoplasty, descemet membrane endothelial keratoplasty (DMEK), descemet stripping endothelial keratoplasty (DSEK), corneal limbal stem cell transplant, and others. The penetrating keratoplasty segment dominated the North America corneal transplantation market in 2020 and descemet membrane endothelial keratoplasty (DMEK) segment is expected to be fastest growing during forecast period. Based on indication, the North America corneal transplantation market is segmented into fungal corneal ulcer, fuchs dystrophy, keratoconus, keratitis, and others. The fuchs dystrophy segment dominated the North America corneal transplantation market in 2020 and same segment is expected to be fastest growing during forecast period. Based on end user, the North America corneal transplantation market is segmented into hospitals, eye clinic, and ambulatory surgical centers. The hospitals segment dominated the North America corneal transplantation market in 2020 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the North America corneal transplantation market has been segmented into the US, Canada, and Mexico.  Alcon Inc.; Aurolab; Cornea Biosciences, Inc.; CorneaGen; Corneat Vision; Florida Lions Eye Bank; Keramed, Inc.; Lifeline Scientific, Inc.; and Massachusetts Eye and Ear are among the leading companies in the North America corneal transplantation market.

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Corneal Transplantation Market – By Type

1.3.2        North America Corneal Transplantation Market – By Indication

1.3.3        North America Corneal Transplantation Market – By End User

1.3.4        North America Corneal Transplantation Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Corneal Transplantation Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Corneal Transplantation Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidence of Eye Diseases

5.1.2        Rise in Geriatric Population

5.2         Market Restraints

5.2.1        Complications Associated with Corneal Transplantation and Shortage of Donor Corneas

5.3         Market Opportunities

5.3.1        Use of High-Tech Products for Transplantation

5.4         Future Trends

5.4.1        Increasing Initiatives from Various Organizations and Governments

5.5         Impact Analysis

6.           Corneal Transplantation Market– North America Analysis

6.1         North America Corneal Transplantation Market Revenue Forecast and Analysis

7.           North America Corneal Transplantation Market Analysis – By Type

7.1         Overview

7.2         North America Corneal Transplantation Market Revenue Share, By Type (2021 and 2028)

7.3         Penetrating Keratoplasty

7.3.1        Overview

7.3.2        Penetrating Keratoplasty: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Descemet Membrane Endothelial Keratoplasty (DMEK)

7.4.1        Overview

7.4.2        Descemet Membrane Endothelial Keratoplasty (DMEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Descemet Stripping Endothelial Keratoplasty (DSEK)

7.5.1        Overview

7.5.2        Descemet Stripping Endothelial Keratoplasty (DSEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Corneal Limbal Stem Cell Transplant

7.6.1        Overview

7.6.2        Corneal Limbal Stem Cell Transplant: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Corneal Transplantation Market Analysis – By Indication

8.1         Overview

8.2         North America Corneal Transplantation Market Revenue Share, By Indication (2021 and 2028)

8.3         Fungal Corneal Ulcer

8.3.1        Overview

8.3.2        Fungal Corneal Ulcer: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fuchs’ Dystrophy

8.4.1        Overview

8.4.2        Fuchs’ Dystrophy: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Keratoconus

8.5.1        Overview

8.5.2        Keratoconus: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Keratitis

8.6.1        Overview

8.6.2        Keratitis: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Corneal Transplantation Market Analysis – By End User

9.1         Overview

9.2         North America Corneal Transplantation Market Share, by End User, 2021 and 2028, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Eye Clinics

9.4.1        Overview

9.4.2        Eye Clinics: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Ambulatory Surgical Centers

9.5.1        Overview

9.5.2        Ambulatory Surgical Centers: Corneal Transplantation Market – Revenue and Forecast to 2028  (US$ Million)

10.        North America Corneal Transplantation Market – Country Analysis

10.1      North America: Corneal transplantation Market

10.1.1     Overview

10.1.2     North America: Corneal Transplantation Market, by Country, 2021 & 2028 (%)

10.1.2.1       US: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       US: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2       U.S. Corneal TransplantationMarket, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       U.S. Corneal TransplantationMarket, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.4       U.S. Corneal TransplantationMarket, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2       Canada: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Canada: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2       Canada Corneal Transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Canada Corneal Transplantation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.4       Canada Corneal Transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3       Mexico: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Mexico: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2       Mexico Corneal Transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Mexico Corneal Transplantation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.4       Mexico Corneal Transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Alcon Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Florida Lions Eye Bank

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Corneat Vision

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Aurolab

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Keramed, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Cornea Biosciences, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Massachusetts Eye and Ear

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Lifeline Scientific, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      San Diego Eye Bank

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             North America Corneal Transplantation Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2.             U.S. Corneal TransplantationMarket, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             U.S. Corneal TransplantationMarket, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4.             U.S. Corneal TransplantationMarket, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Corneal Transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Corneal Transplantation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Corneal Transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico Corneal Transplantation Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Corneal Transplantation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Corneal Transplantation Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           North America Corneal Transplantation Market Segmentation

Figure 2.           North America Corneal Transplantation Market, By Country

Figure 3.           North America Corneal Transplantation Market Overview

Figure 4.           Penetrating Keratoplasty Segment Held the Largest Share of the Market in 2021

Figure 5.           The US Held the Largest Share of the Market in 2021

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Corneal Transplantation Market Impact Analysis of Driver and Restraints

Figure 9.           North America Corneal Transplantation Market– Revenue Forecast and Analysis to 2028

Figure 10.        North America Corneal Transplantation Market Revenue Share, By Type (2021 and 2028)

Figure 11.        North America Penetrating Keratoplasty: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Descemet Membrane Endothelial Keratoplasty (DMEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Descemet Stripping Endothelial Keratoplasty (DSEK): Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Corneal Limbal Stem Cell Transplant: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Others: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Corneal Transplantation Market Revenue Share, By Indication (2021 and 2028)

Figure 17.        North America Fungal Corneal Ulcer: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Fuchs’ Dystrophy: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Keratoconus: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Keratitis: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Others: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Corneal Transplantation Market Share, by End User, 2021 and 2028 (%)

Figure 23.        North America Hospitals: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Eye Clinics: Corneal transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Ambulatory Surgical Centers: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America: Corneal Transplantation Market, by Key Country – Revenue (2021) (US$ Million)

Figure 27.        North America: Corneal Transplantation Market, by Country, 2021 & 2028 (%)

Figure 28.        US: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Canada: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Mexico: Corneal Transplantation Market – Revenue and Forecast to 2028 (US$ Million)

  1. Alcon Inc.
  2. Aurolab
  3. Cornea Biosciences, Inc.
  4. CorneaGen
  5. Corneat Vision
  6. Florida Lions Eye Bank
  7. Keramed, Inc.
  8. Lifeline Scientific, Inc.
  9. Massachusetts Eye and Ear
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America corneal transplantation market.       
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America corneal transplantation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the corneal transplantation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000